dc.contributor.author | Cao, Huan | |
dc.contributor.author | Neerincx , Andreas | |
dc.contributor.author | de Bono , Bernard | |
dc.contributor.author | Lakner , Ursula | |
dc.contributor.author | Huntington , Catherine | |
dc.contributor.author | Elvin, John | |
dc.contributor.author | Gudgin , Emma | |
dc.contributor.author | Pridans, Clare | |
dc.contributor.author | Vickers, Mark | |
dc.contributor.author | Huntly, Brian | |
dc.contributor.author | Trowsdale, John | |
dc.contributor.author | Barrow , Alexander | |
dc.date.accessioned | 2021-05-28T19:10:02Z | |
dc.date.available | 2021-05-28T19:10:02Z | |
dc.date.issued | 2021-06-01 | |
dc.identifier.citation | Cao , H , Neerincx , A , de Bono , B , Lakner , U , Huntington , C , Elvin , J , Gudgin , E , Pridans , C , Vickers , M , Huntly , B , Trowsdale , J & Barrow , A 2021 , ' Sialic acid‐binding immunoglobulin‐like lectin (Siglec)‐15 is a rapidly internalised cell‐surface antigen expressed by acute myeloid leukaemia cells ' , British Journal of Haematology , vol. 193 , no. 5 , pp. 946-950 . https://doi.org/10.1111/bjh.17496 | en |
dc.identifier.issn | 0007-1048 | |
dc.identifier.other | PURE: 190823057 | |
dc.identifier.other | PURE UUID: 6c972785-cf91-4a88-9924-34f9b245172b | |
dc.identifier.other | Jisc: 7e6f483e94e444e68a136337b0a6a95b | |
dc.identifier.other | ORCID: /0000-0002-3154-1040/work/93483241 | |
dc.identifier.other | PubMed: 33951750 | |
dc.identifier.other | Scopus: 85105041877 | |
dc.identifier.other | WOS: 000647261000001 | |
dc.identifier.uri | https://hdl.handle.net/2164/16570 | |
dc.description | Acknowledgements This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) Collaborative Awards in Science and Engineering (CASE) award (to Huan Cao) as well as Wellcome Trust (089821/Z/09/Z) and UK Medical Research Council (MRC) (G0901682) grants. Alexander D. Barrow was funded by a Marie Curie International Outgoing Fellowship (EC 236932). John Trowsdale received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 695551). | en |
dc.format.extent | 5 | |
dc.language.iso | eng | |
dc.relation.ispartof | British Journal of Haematology | en |
dc.rights | This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Siglec‐15 | en |
dc.subject | acute myeloid leukaemia | en |
dc.subject | antibody | en |
dc.subject | phage display | en |
dc.subject | endocytosis | en |
dc.subject | R Medicine | en |
dc.subject | Wellcome Trust | en |
dc.subject | 089821/Z/09/Z | en |
dc.subject | Other | en |
dc.subject | Marie Curie EC236932 | en |
dc.subject | European Research Council 695551 | en |
dc.subject | Biotechnology and Biological Sciences Research Council (BBSRC) | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | G0901682 | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.title | Sialic acid‐binding immunoglobulin‐like lectin (Siglec)‐15 is a rapidly internalised cell‐surface antigen expressed by acute myeloid leukaemia cells | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1111/bjh.17496 | |